Clinical trials
Trials in Cambodia with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2011 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ANRS, Emerging Infectious Diseases | 6 |
| Armed Forces Research Institute of Medical Sciences, Thailand | 3 |
| Children's Surgical Center, Cambodia | 1 |
| Institut Pasteur | 1 |
| Institut de Recherche pour le Developpement | 1 |
| Institut de Recherche pour le Developpement, Cambodia | 1 |
| Khon Kaen University | 1 |
| National Institute of Public Health, Cambodia | 1 |
| Touro University, California | 1 |
| University of California, Berkeley | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Malaria | 3 |
| HIV Infections | 2 |
| Malaria, Falciparum | 2 |
| Tuberculosis | 2 |
| Uterine Cervical Neoplasms | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Breast Neoplasms | 1 |
| Child Nutrition Disorders | 1 |
| Encephalitis | 1 |
| Encephalitis, Japanese | 1 |
Trials
Showing 76 to 19 of 19. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.